Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Safety and Feasibility Study of Personalized Immunotherapy in Adults With Advanced Cancers

NCT03568058 is registered in ClinicalTrials.gov with Aaron Miller as lead sponsor.

NCT NCT03568058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03568058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Safety and Feasibility Study of Personalized Immunotherapy in Adults With Advanced Cancers
Lead sponsor
Aaron Miller
Phase
Phase 1
Overall status
Completed
Start date
July 26, 2018
Completion date
January 27, 2025
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer